House subcommittee schedules February hearings on user fees

01/12/2012 | Hill, The

A House Energy and Commerce health subcommittee will discuss the Prescription Drug User Fee Act on Feb. 1 and proposed user fees for biosimilars Feb. 7. The subcommittee also scheduled a hearing Feb. 15 on reauthorization of the FDA's user-fee program for devices.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Chief Medical Officer
Meritus
Tempe, AZ
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX